News Veeva buys brand engagement firm Ostro for $100m Veeva Systems has reached a $100m deal to acquire Ostro, which helps pharma connect with doctors and patients using AI-based conversational tools.
Digital From engagement metrics to meaningful experience: Why pharma... Pharma digital success still focuses on clicks and downloads, but true performance is whether content actually meets real end-user needs
Sales & Marketing Bad KOL data is expensive: Harnessing high-quality data for ... As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.
Digital How to build a measurement framework to enable digital produ... Between digital therapeutics, HCP portals, and patient support communications, pharma companies are investing a significant portion of their revenues on digital products.
Sales & Marketing Sponsored Unlocking the full power of data for Pharma The value of data has never been greater in healthcare.
Sales & Marketing Measuring success in pharma marketing: Does engagement equat... Is engagement the equivalent of a “digital smile” in pharma marketing, or have we been measuring communications efficacy all wrong?
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.